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burden of diabetes among working-age
adults in Asia: conservative estimates for
Singapore from 2010-2050’
May Ee Png1, Joanne Yoong1,2*, Thao Phuong Phan1 and Hwee Lin Wee3Unfortunately, the original version of this article [1] con-
tained an error. After publication the authors became aware
of the mistakes in computing the proportions of excess dir-
ect medical costs and indirect productivity-related losses in
the Abstract, Results and Discussion (described as follows).
The proportion of excess direct medical costs and indirect
productivity-related losses in 2010 were updated from 42 to
26 % and 58 % to 74 % respectively. Likewise, the share of
indirect costs in 2050 rose to 81 % instead of 65 % as previ-
ously written with the direct medical cost reduced to 19 %
instead of 35 %. In the Discussion section, in the U.S., 72 %
of the total economic burden for diabetes patients is direct
medical costs, compared to 26 % instead of 42 % in
Singapore.
In making these changes we became aware of two other
errors that had not been corrected at final draft stage of
the publishing process. These are described below:
i. Under the sub-section Cost estimation of absentee-
ism from Methods section, the average wage for
Singaporean residents in 2010 that was used in the
analysis was US$3,446 for males and US$2525 for
females instead of US$3,004.
ii. The values in the Sensitivity analyses sub-section from
Results section were the incremental differences from
baseline values. Hence, the paragraph should read:
The total cost per patient among 20–29 years old
would increase by up to US$12,361 from base case
estimate while those among 30–39 would increase by
up to US$5,533 and decrease by up to US$2,520 from* Correspondence: jyoong@usc.edu
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ential parameter on total cost per patient in 2050 for
those aged 40–59 years old. The total cost per patient
among 40–49 years old would grow by up to
US$4,993 and reduce by up to US$3,407 from base
case estimate while those among 50–59 would grow
by up to US$5,572 and reduce by up to US$3,802
from base case estimate. Lastly, for those aged 60–69,
the excess direct medical cost of diabetes was the
most influential on total cost per patient in 2050 with
cost that would increase by up to US$4,966 and
reduce by up to US$988 from base case estimate.
None of the conclusions reached in the uncorrected
version of the paper has been revised in the light of
these changes.
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